BPaL regimen Current Affairs, GK & News

PRETOMANID: US FDA approves new drug for drug-resistant TB

August 17, 2019

United States (US) Food and Drug Administration (FDA) has approved new drug-Pretomanid for treating drug-resistant strain of Tuberculosis (TB). Pretomanid is novel compound developed by New York-based non-profit organisation TB Alliance. It is used alongside two other antibiotics (bedaquiline and linezolid) to treat extremely drug-resistant strain of tuberculosis. This three-drug regimen is collectively known as ..

Month: 

Category: 

Topics:  • • • • • • • •